Page last updated: 2024-09-03

gefitinib and nutlin-3a

gefitinib has been researched along with nutlin-3a in 1 studies

Compound Research Comparison

Studies
(gefitinib)
Trials
(gefitinib)
Recent Studies (post-2010)
(gefitinib)
Studies
(nutlin-3a)
Trials
(nutlin-3a)
Recent Studies (post-2010) (nutlin-3a)
5,2315662,9196981504

Protein Interaction Comparison

ProteinTaxonomygefitinib (IC50)nutlin-3a (IC50)
Protein Mdm4Homo sapiens (human)4.6273
Cellular tumor antigen p53Homo sapiens (human)1.0388
Cytochrome P450 2C19Homo sapiens (human)0.07
E3 ubiquitin-protein ligase Mdm2Homo sapiens (human)0.1832

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fu, Y; He, Q; Lin, G; Lou, J; Ma, J; Wu, Y; Yang, B; Zheng, L; Zhu, H1

Other Studies

1 other study(ies) available for gefitinib and nutlin-3a

ArticleYear
Nutlin-3 inhibits epithelial-mesenchymal transition by interfering with canonical transforming growth factor-β1-Smad-Snail/Slug axis.
    Cancer letters, 2014, Jan-01, Volume: 342, Issue:1

    Topics: Antigens, CD; Antineoplastic Agents; Cadherins; Cell Line, Tumor; Cell Movement; Drug Evaluation, Preclinical; Drug Synergism; Epithelial-Mesenchymal Transition; ErbB Receptors; Gefitinib; Gene Expression; Humans; Imidazoles; Lapatinib; Phosphorylation; Piperazines; Protein Kinase Inhibitors; Protein Processing, Post-Translational; Quinazolines; RNA, Messenger; Signal Transduction; Smad Proteins; Snail Family Transcription Factors; Transcription Factors; Transforming Growth Factor beta1; Up-Regulation

2014